HOYFF yields 3.67% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, HOYFF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HOYFF + MRK for your $10,000?
Huhtamäki Oyj manufactures and sells packaging products in the United States, Germany, India, the United Kingdom, Australia, Thailand, China, South Africa, Russia, the United Arab Emirates, Findland, and internationally. It operates in foodservice packaging, flexible packaging, and fiber packaging business areas. The company offers single and double-wall paper cups, coffee cups, cold drinks cups, cup carriers, lids, accessories, and short run prints of customized paper cups; take away trays, containers, clamshells, scoops, bowls, wraps, and various accessories for take-away and dining; and egg trays, egg cartons, fruit trays, and wine bottle separators. It also provides multilayer films, wrappers, labels, pouches, and various reclose and print options for coffee, tea, juice, energy drink, and alcoholic beverage packaging; and stand up pouches, food pouches, multilayer packaging, and foils for ice cream, soups, biscuits, confectionary, dry foods, and other retail foods. In addition, the company offers ready-to-eat pet food packaging, such as retort pouches and barrier laminates, as well as open and reclosable bags, and pouches in aluminum foil and non-foil transparent structures; packaging and labels for personal and home care products; tube laminates for toothpaste and other tubes; and blister packaging materials and pharmaceutical packaging. Further, it provides catering disposables and vending cups; food service paper and disposable tableware to foodservice operators, fast food restaurants, and coffee shops; packaging solutions for retail business; flexible packaging solutions. Huhtamäki Oyj was founded in 1920 and is headquartered in Espoo, Finland.
Full HOYFF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.